Argus Downgrades Novo Nordisk (NVO) to Hold
Tweet
Share
E-mail
Get Alerts NVO Hot Sheet
Price: $46.74 +1.30%
Rating Summary:
8 Buy, 17 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
8 Buy, 17 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Argus analyst John Eade downgraded Novo Nordisk (NYSE: NVO) from Buy to Hold.
For an analyst ratings summary and ratings history on Novo Nordisk click here. For more ratings news on Novo Nordisk click here.
Shares of Novo Nordisk closed at $47.86 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades AAC Technologies Holdings Inc. (2018:HK) (AACAY) to Neutral
- BofA says CTA Treasury shorts stable, euro short-cover risk rises
- Jefferies sees metals breakout on currency concerns
Create E-mail Alert Related Categories
DowngradesRelated Entities
Argus, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
